Companies / Switzerland
Roche Restructures R&D Operations
February 2007 | Industry NewsSwiss drugmaker Roche has announced that it is to reorganise its R&D operations in order to help create a more competitive pipeline. The move comes at a time when innovation in the drug industry is becoming increasingly scarce and follows similar restructuring at major rivals such as UK-based GlaxoSmithKline (GSK) and AstraZeneca
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
